69
Views
6
CrossRef citations to date
0
Altmetric
Research Article

CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience

Pages 799-804 | Published online: 01 Jul 2009

  • Rabkin, C.S., Devesa, S.S., Zahm, S.H. and Gail, M.H. (1993) "Increasing incidence of non-Hodgkin's lymphoma", Semin. Hematol. 286-296, 1993.
  • Harris, N.L., Jaffe, E.S., Diebold, J., et al., (1999) "The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues", Ann. Oncol. 10, 1419-1432.
  • Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Am Stat. Assoc. J. 53, 457-481.
  • Cox, D.R. (1972) "Regression models and life-tables", J. R. Stat. Soc. B 34, 187-220.
  • McKelvey, E.M., Gottlieb, J.A., Wilson, H.E., et al., (1976) "Hydroxyldaunorubicin (adriamycin) combination chemotherapy in malignant lymphoma", Cancer 38, 1484-1493.
  • Cultman, C.A., Dahlberg, S., Jones, S.E., et al. (1986) "CHOP is curative in thirty percent of patients with large-cell lymphoma: a 12-year Southwest Oncology Group (SWOG) follow-up", In: Sharin, A.T., ed. Advances in Cancer Chemotherapy Update of Treatment for Diffuse Large-cell Lymphoma (??. New York), pp 71-82.
  • Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma", Ann. Intern. Med. 102, 596-602.
  • Longo, D.L., De Vita, Jr. V.T., Duffey, P.L., et al., (1991) "Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial", J. Clin. Oncol. 9, 25-38.
  • Skarin, A.T., Canellos, G.P., Rosenthal, D.S., et al., (1983) "Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)", J. Clin. Oncol. 1, 91-98.
  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., et a;., (1993) "Comparison of a standard regimen (CHOP) with three intensive regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med. 328, 1002-1006.
  • Cancer Statistics 2000(2000) "CA: a cancer", Journal for Clinicians, 7-34.
  • The International Non-Hodgkin's lymphoma Prognostic Factor Project(1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med. 329, 987-994.
  • Vose, J.M., Armitage, J.O., Weisenburger, D.D., et al., (1988) "The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma", J. Clin. Oncol. 6, 1838-1844.
  • Gomez, H., Hidalgo, M., Casanova, L., et al., (1998) "Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis", J. Clin. Oncol. 16, 2065-2069.
  • Meyer, B.M., Browman, G.P. Samosh, ML., et al., (1995) "Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma", J. Clin. Oncol. 13, 2386-2393.
  • Martelli, M., Gugliehni, C., Coluzzi, S., et al., (1993) "P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodpkin's lymphoma", J. Clin Oncol. 11, 2362-2369.
  • Zinzani, P.L., Storti, S., Zaccaria, A., et al., (1999) "Elderly aggressive histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients", Blood 94, 33-38.
  • Meyer, R.M., Hryniuk, W.M. and Goodyear. M.D.E. (1991) "The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma", J. Clin. Oncol. 9, 339-347.
  • O'Reilly, S.E., Connors, J.M., Howdle, S., et al., (1993) "In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy", J. Clin Oncol. 11, 2250- 2257.
  • Sonneveld, P., de Ridder, M., van der Lelie, H., et al., (1995) "Comparison of Doxorubicin and Mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy", J. Clin. Oncol. 13, 2530-2539.
  • Bjorkholm, M., Osby, F., Hagberg, H., et al., (1999) "Randomized trial of r-metHu granulocyte colony stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma", Blood 94, 2665a.
  • Bezwoda, W., Rastogi, T.B., Valla, A.E., et al., (1995) "Long-term results of a multicentre randomized, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate and high-grade non-Hodgkin's lymphomas", Euro. J. Cancer 31. 903-911.
  • Pavlovsky, S., Samarelli, M.T., Erazo, A., et al., (1992) "Results of a randomized study of previously untreated intermediate- and high-grade lymphoma using CHOP versus CNOP", Ann. Oncol. 3, 205-209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.